Want to add to the conversation? login or Join Today!

Thank you for visiting the AASLD Engage Online Community page. These online communities are an exclusive member benefit for the AASLD Special Interest Group (SIG) members. AASLD's 16 Special Interest Groups are open for all AASLD Members to join and cover nearly every aspect of Hepatology.

If you are not an AASLD Member but wish to join to gain access to these online communities, complete your Membership Application Today!

Latest Discussions

  • Yes! It would be really helpful if we could agree to universal definitions of remission and relapse. I agree with Michele we should use either AST or ALT. My only concern is using an isolated IgG >1.3x ULN could result in too many false positives (mostly ... Login

  • Posted in: Hepatitis B (SIG)

    ------------------------------ Lloyd the Liver Research Assistant Alexandria VA ------------------------------ Login

  • How about AST or ALT > 2x ULN OR IgG > 1.3x ULN Great question, Josh! --------------------------------- Michele Tana MD Attending Physician University of California, San Francisco San Francisco CA --------------------------------- Login

  • Option 4 seems most suitable: ALT>2ULN and /or IgG>2 Login

  • I vote  for ALT >2ULN and /or iGG>2 in the setting of rising AST ------------------------------ Walid Ayoub MD, FAASLD Clinical Associate Professor Cedars-Sinai Medical Center Los Angeles CA ------------------------------ Login

  • Posted in: Hepatitis B (SIG)

    AASLD Webinar on Chronic Liver Disease & COVID-19 (Thursday, April 22, 2021) 6-7 pm EST This is a patient-centered webinar providing an overview on the risk of COVID-19 in patients with underlying liver disease. The webinar will feature four presentations ... Login

  • Dear Early Career Investigators, The Cholestatic & Autoimmune Liver Diseases SIG has put together an exciting clinical case study that is free to everyone.  The first case study is being held at 8:00pm EDT on Thursday, April 22nd and here are the details:  ... Login

  • Dear Members of the AASLD Pediatric Liver Disorders SIG, I am very excited to inform you that the Cholestatic & Autoimmune Liver Diseases SIG is launching a series SIG events for the presentation of challenging clinical cases and journal club articles ... Login

  • Dear Colleagues, Just a quick reminder to register for our first case study hosted by our SIG at 8:00pm EDT on Thursday, April 22nd. Here is the link to register and attached is a flyer that you can send around to any interested people: Reserve your ... Login

  • Hi everyone Interested in thoughts on an acceptable definition of relapse following (or during) IS withdrawal, mainly for clinical trial development as a primary endpoint. Looking at the literature, the definition is all over the place in prior studies, ... Login